Cargando…

In Vivo Imaging Enables High Resolution Preclinical Trials on Patients’ Leukemia Cells Growing in Mice

BACKGROUND: Xenograft mouse models represent helpful tools for preclinical studies on human tumors. For modeling the complexity of the human disease, primary tumor cells are by far superior to established cell lines. As qualified exemplary model, patients’ acute lymphoblastic leukemia cells reliably...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terziyska, Nadia, Alves, Catarina Castro, Groiss, Volker, Schneider, Katja, Farkasova, Katarina, Ogris, Manfred, Wagner, Ernst, Ehrhardt, Harald, Brentjens, Renier J., zur Stadt, Udo, Horstmann, Martin, Quintanilla-Martinez, Leticia, Jeremias, Irmela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534096/ https://www.ncbi.nlm.nih.gov/pubmed/23300782 http://dx.doi.org/10.1371/journal.pone.0052798

Ejemplares similares

Efficient RNA interference in patients' acute lymphoblastic leukemia cells amplified as xenografts in mice
por: Höfig, Ines, et al.
Publicado: (2012)

NOXA as critical mediator for drug combinations in polychemotherapy
por: Ehrhardt, H, et al.
Publicado: (2012)

Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling
por: Wachter, Franziska, et al.
Publicado: (2013)

Characterization of novel, recurrent genomic rearrangements as sensitive MRD targets in childhood B-cell precursor ALL
por: zur Stadt, Udo, et al.
Publicado: (2019)

Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR)
por: Weber, Axel, et al.
Publicado: (2012)

Engineering strategies to overcome the current roadblocks in CAR T cell therapy
por: Rafiq, Sarwish, et al.
Publicado: (2019)

Plasticity in growth behavior of patients’ acute myeloid leukemia stem cells growing in mice
por: Ebinger, Sarah, et al.
Publicado: (2020)

How do CARs work?: Early insights from recent clinical studies targeting CD19
por: Davila, Marco L., et al.
Publicado: (2012)

CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience
por: Palomba, M Lia, et al.
Publicado: (2022)

EGF Receptor-Targeted Synthetic Double-Stranded RNA Eliminates Glioblastoma, Breast Cancer, and Adenocarcinoma Tumors in Mice
por: Shir, Alexei, et al.
Publicado: (2006)

Correction: EGF Receptor-Targeted Synthetic Double-Stranded RNA Eliminates Glioblastoma, Breast Cancer, and Adenocarcinoma Tumors in Mice
por: Shir, Alexei, et al.
Publicado: (2007)

Toxicity and management in CAR T-cell therapy
por: Bonifant, Challice L, et al.
Publicado: (2016)

Multipurposing CARs: Same engine, different vehicles
por: Hossian, A.K.M. Nawshad, et al.
Publicado: (2022)

A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer
por: Koneru, Mythili, et al.
Publicado: (2015)

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
por: Yeku, Oladapo O., et al.
Publicado: (2017)

Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group.
por: Escherich, Gabriele, et al.
Publicado: (2021)

A reporter system for enriching CRISPR/Cas9 knockout cells in technically challenging settings like patient models
por: Liu, Wen-Hsin, et al.
Publicado: (2021)

COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia
por: Lopes, Bruno Almeida, et al.
Publicado: (2016)

Cytokine IL-36γ Improves CAR T Cell Functionality and Induces Endogenous Anti-Tumor Response
por: Li, Xinghuo, et al.
Publicado: (2020)

Growing Pains
por: Katarina Anthony
Publicado: (2013)

Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis
por: Bode, Sebastian FN, et al.
Publicado: (2012)

Acute myeloid leukemia arising from a donor derived premalignant hematopoietic clone: A possible mechanism for the origin of leukemia in donor cells
por: Dickson, Mark A., et al.
Publicado: (2014)

Gene Therapy for Advanced Melanoma: Selective Targeting and Therapeutic Nucleic Acids
por: Viola, Joana R., et al.
Publicado: (2013)

Insights into the Black Box of Intra-Amniotic Infection and Its Impact on the Premature Lung: From Clinical and Preclinical Perspectives
por: Dong, Ying, et al.
Publicado: (2022)

CD103(+) cDC1 and endogenous CD8(+) T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
por: Kuhn, Nicholas F., et al.
Publicado: (2020)

An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging
por: Vick, Binje, et al.
Publicado: (2015)

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade
por: Ruzicka, Michael, et al.
Publicado: (2019)

Influence of preparation design on the quality of tooth preparation in preclinical dental education
por: Hey, Jeremias, et al.
Publicado: (2017)

Oxygen Toxicity to the Immature Lung—Part I: Pathomechanistic Understanding and Preclinical Perspectives
por: Choi, Yesi, et al.
Publicado: (2021)

Novel PAMAM-PEG-Peptide Conjugates for siRNA Delivery Targeted to the Transferrin and Epidermal Growth Factor Receptors
por: Urbiola, Koldo, et al.
Publicado: (2018)

Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis
por: Ehrhardt, H, et al.
Publicado: (2013)

Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells
por: Park, Jae H, et al.
Publicado: (2018)

Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia
por: Jin, Chun-Hui, et al.
Publicado: (2018)

Generation of a tumor- and tissue-specific episomal non-viral vector system
por: Haase, Rudolf, et al.
Publicado: (2013)

IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
por: Jaspers, Janneke E., et al.
Publicado: (2023)

A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape
por: Kellner, Markus, et al.
Publicado: (2022)

Ulceration in Prolidase Deficiency: Successful Treatment with Anticoagulants
por: SÜßMUTH, Kira, et al.
Publicado: (2020)

Preclinical Evaluation of Lipid-Based Nanosystems
por: Silva, Ana Catarina, et al.
Publicado: (2021)

CLUE: a bioinformatic and wet-lab pipeline for multiplexed cloning of custom sgRNA libraries
por: Becker, Martin, et al.
Publicado: (2020)

Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells
por: Dixon, Brianne N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b9s0l5c3k2ubi3dd7rfsuvsi7b